Busulfan Injection — FDA Drug Shortage

No longer listed by FDA — Mylan Institutional, A Viatris Company

The FDA lists a drug shortage record for Busulfan Injection (injection) from Mylan Institutional, A Viatris Company with status No longer listed by FDA. The shortage was first posted on Oct 24, 2025.

Shortage details

Status
No longer listed by FDA
Company
Mylan Institutional, A Viatris Company
Package NDC
67457-893-08
Dosage Form
Injection
Presentation
Busulfan, Injection, 6 mg/1 mL (NDC 67457-893-08)
Initial Posting
Oct 24, 2025

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.